How effective is Flecainide Acetate for A-fib (Atrial fibrillation/flutter)? (a real world drug study)
Summary:
Overall ratings: 3.8/5 Long term ratings: 3.9/5
This is a phase IV clinical study of how effective Flecainide acetate (flecainide acetate) is for A-fib and for what kind of people. The study is created by eHealthMe from 391 Flecainide acetate users and is updated continuously.
What is Flecainide acetate?
Flecainide acetate has active ingredients of flecainide acetate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 7,176 Flecainide acetate users. Check the latest studies of Flecainide acetate.
What is A-fib?
A-fib (most common type of arrhythmia) is found to be associated with 2,896 drugs and 3,840 conditions by eHealthMe. Check the latest studies of A-fib.
391 people are studied for taking Flecainide acetate in A-fib
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Flecainide acetate effectiveness for A-fib (number of people):
Overall:
- not at all: 2
- somewhat: 41
- moderate: 88
- high: 181
- very high: 79
Long Term:
- not at all: 0
- somewhat: 20
- moderate: 43
- high: 120
- very high: 63
Gender of people who take Flecainide acetate for A-fib *:
- female: 43.22 %
- male: 56.78 %
Age of people who take Flecainide acetate for A-fib *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.26 %
- 20-29: 1.02 %
- 30-39: 2.81 %
- 40-49: 5.88 %
- 50-59: 20.46 %
- 60+: 69.57 %
Who find Flecainide Acetate more effective for A-fib?
Gender of people who take Flecainide acetate for A-fib *:
- female: 41.92 %
- male: 58.08 %
Age of people who take Flecainide acetate for A-fib *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.38 %
- 30-39: 2.31 %
- 40-49: 6.92 %
- 50-59: 18.08 %
- 60+: 72.31 %
* Approximation only. Some reports may have incomplete information.
Do you take Flecainide acetate?
- You can start a phase IV clinical trial to monitor Flecainide acetate safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Flecainide acetate (7,176 reports)
Treatments, associated drugs and conditions:
- A-fib (349,226 reports)
How the study uses the data?
The study is based on flecainide acetate (the active ingredients of Flecainide acetate) and Flecainide acetate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cymbalta cause Reflux Oesophagitis? - 8 seconds ago
- Hyperparathyroidism and Rashes - 32 seconds ago
- Could Flexeril cause Injection Site Haemorrhage? - a minute ago
- Could Miralax cause Proctalgia? - a minute ago
- Drug interactions of Colecalciferol and Felodipine - a minute ago
- Iron Deficiency and Vision Blurred - a minute ago
- Drug interactions of Betamethasone Dipropionate and Lovastatin - a minute ago
- Could Sarafem cause Dyspnea? - a minute ago
- Could Mobic cause Adrenal Insufficiency? - 2 minutes ago
- Could Cymbalta cause Infusion Site Rash? - 2 minutes ago